MedPath

Cefusaph-750

Brand Name: Cefusaph-750

Generic Name: Cefuroxime (as Sodium)

Active
Registration Number

DRP-11017

Dosage Form

Powder For Injection (IV/IM)

Issuance Date

February 1, 2023

Expiry Date

February 11, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength750 mg
PackagingType I Flint Glass Vial with Gray Bromobutyl Rubber Stopper and Blue Flip-Off Seal Cap x l's + Sterile Water for Injection in Clear Glass Ampoule x 10 mL (Box of l's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antibacterial (Cephalosporin)
A
Application
Initial (Correction)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Cefuroxime (as Sodium)Active
Monograph: cefuroxime (as sodium)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform